BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7892123)

  • 1. [Basal cell cancer--current research sheds new light].
    Ståhle-Bäckdahl M
    Nord Med; 1995; 110(3):82-4. PubMed ID: 7892123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apoptosis in basal cell and squamous cell carcinoma formation.
    Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
    Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele.
    van der Riet P; Karp D; Farmer E; Wei Q; Grossman L; Tokino K; Ruppert JM; Sidransky D
    Cancer Res; 1994 Jan; 54(1):25-7. PubMed ID: 8261448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
    Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
    Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of hereditary factors in synchronous development of Basal cell carcinoma in two albino brothers: case report.
    Başkurt H; Celik E; Yeşiladali G; Tercan M
    Ann Plast Surg; 2011 Jun; 66(6):640-2. PubMed ID: 21407072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer.
    Young LC; Listgarten J; Trotter MJ; Andrew SE; Tron VA
    Br J Dermatol; 2008 Jan; 158(1):59-69. PubMed ID: 17970804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
    Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
    Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aetiology and pathogenesis of basal cell carcinoma.
    Tilli CM; Van Steensel MA; Krekels GA; Neumann HA; Ramaekers FC
    Br J Dermatol; 2005 Jun; 152(6):1108-24. PubMed ID: 15948971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary tumour syndromes featuring basal cell carcinomas.
    Parren LJ; Frank J
    Br J Dermatol; 2011 Jul; 165(1):30-4. PubMed ID: 21428980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor.
    Walther U; Kron M; Sander S; Sebastian G; Sander R; Peter RU; Meurer M; Krähn G; Kaskel P
    Br J Dermatol; 2004 Jul; 151(1):170-8. PubMed ID: 15270887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss on chromosome 9q22.2-22.3 in sporadic basal cell carcinoma in Chinese.
    He C; Zhang X; Wang Y; Sun K; Chen HD
    Chin Med J (Engl); 1999 Jun; 112(6):497-500. PubMed ID: 11601325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hedgehog signalling pathway and cancer.
    Saldanha G
    J Pathol; 2001 Apr; 193(4):427-32. PubMed ID: 11276000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
    Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
    Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific characteristics of skin basal cell carcinoma invasion].
    Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
    Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
    Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors determining cutaneous basal cell carcinoma phenotype.
    Ramachandran S; Fryer AA; Strange RC
    Med Pediatr Oncol; 2001 May; 36(5):559-63. PubMed ID: 11340612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age.
    D'Errico M; Calcagnile AS; Corona R; Fucci M; Annessi G; Baliva G; Tosti ME; Pasquini P; Dogliotti E
    Cancer Res; 1997 Feb; 57(4):747-52. PubMed ID: 9044855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
    Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
    J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.